Showing results (1-10 of 99) with videos related to
Sort By:
Pageof 10
New Journal of Science|March 18, 2014
Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapyDavid EscorsArchivum Immunologiae Et Therapiae Experimentalis|February 10, 2010
Lentiviral vectors in gene therapy: their current status and future potentialDavid Escors, Karine BreckpotEndocrine, Metabolic & Immune Disorders Drug Targets|October 28, 2009
Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modificationKarine Breckpot, David EscorsJournal of Virological Methods|May 26, 2004
Immunopurification applied to the study of virus protein composition and encapsidationDavid Escors, Carmen Capiscol, Luis EnjuanesMethods in Cell Biology|March 30, 2024
Assessment of myeloid-derived suppressor cell differentiation ex vivoEster Blanco, David Escors, Grazyna KochanCancers|October 1, 2013
Lentiviral vectors for cancer immunotherapy and clinical applicationsTherese Liechtenstein, Noemi Perez-Janices, David EscorsJournal of Virology|October 22, 2002
Generation of a replication-competent, propagation-deficient virus vector based on the transmissible gastroenteritis coronavirus genomeJavier Ortego, David Escors, Hubert Laude, et al.Current Cancer Therapy Reviews|September 18, 2012
Targeting lentiviral vectors for cancer immunotherapyFrederick Arce, Karine Breckpot, Mary Collins, et al.Journal of Virology|June 28, 2003
Transmissible gastroenteritis coronavirus packaging signal is located at the 5' end of the virus genomeDavid Escors, Ander Izeta, Carmen Capiscol, et al.Oncoimmunology|February 1, 2014
Role of non-classical MHC class I molecules in cancer immunosuppressionGrazyna Kochan, David Escors, Karine Breckpot, et al.Pageof 10